project id: TCGA-BLCA; case submitter id: TCGA-CU-A0YR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; source center: 23; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 83; days to birth: -30674; days to death: 460; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1927; age at diagnosis: 30674; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 219.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 184; days to sample procurement: 0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0;